AbbVie Inc. (NYSE:ABBV)

An examination of the financial information reveals trends in profitability metrics over a five-year period. While initial years demonstrate relative stability, a noticeable shift occurs from 2022 onwards, particularly impacting bottom-line profitability. The analysis focuses on the progression of earnings measures, specifically net earnings, earnings before tax, earnings before interest and tax, and earnings before interest, tax, depreciation and amortization.

Overall Earnings Trend

Net earnings attributable to AbbVie Inc. exhibited modest growth between 2021 and 2022, increasing from US$11,542 million to US$11,836 million. However, a significant decline is observed in 2023, falling to US$4,863 million, and continues to decrease in 2024 to US$4,278 million. A slight recovery is indicated in 2025, with net earnings reaching US$4,226 million, but remains substantially below the levels seen in 2021 and 2022.

EBITDA Performance

EBITDA, a measure of operational profitability, mirrored the overall earnings trend. It increased slightly from US$23,933 million in 2021 to US$24,174 million in 2022. A substantial decrease is then apparent in 2023, with EBITDA dropping to US$17,172 million. This downward trend continues into 2024, reaching US$14,910 million, before showing some improvement in 2025, rising to US$17,629 million. Despite the 2025 increase, EBITDA remains below the levels recorded in 2021 and 2022.

Relationship between EBT and EBIT

The difference between Earnings Before Tax (EBT) and Earnings Before Interest and Tax (EBIT) remained relatively consistent between 2021 and 2022, with interest expense averaging approximately US$2,423 million. However, this difference widens considerably in 2023, 2024, and 2025, suggesting a potential change in the company’s capital structure or interest rate environment. The gap between EBIT and EBT increased significantly, indicating a larger impact from interest expenses or other factors affecting taxable income.

EBIT to EBITDA Margin

The progression from EBIT to EBITDA reveals the impact of depreciation and amortization. The difference between these two metrics remained relatively stable in the initial years, but the decline in EBIT from 2023 onwards resulted in a proportionally larger decrease in EBITDA, suggesting that depreciation and amortization expenses represent a significant portion of overall earnings. This indicates a potentially capital-intensive business model.

In summary, the period under review demonstrates a clear shift in financial performance. While the initial years show modest growth or stability, a significant decline in profitability is observed from 2023, with a partial recovery indicated in 2025. The trends across net earnings, EBT, EBIT, and EBITDA are consistent, pointing to a broad-based impact on the company’s financial results.

The Enterprise Value to EBITDA ratio exhibits a notable upward trend over the observed period. Initially, the ratio remained relatively stable, followed by a significant increase in later years. Enterprise Value demonstrated consistent growth throughout the period, while EBITDA experienced fluctuations.

Enterprise Value

Enterprise Value increased from US$321,636 million in 2021 to US$459,783 million in 2025. The growth was consistent year-over-year, indicating a rising overall valuation of the company, considering both equity and debt.

EBITDA

EBITDA showed a modest increase from US$23,933 million in 2021 to US$24,174 million in 2022. However, a substantial decrease was observed in 2023, falling to US$17,172 million. EBITDA continued to decline in 2024, reaching US$14,910 million, before partially recovering to US$17,629 million in 2025. This volatility suggests potential operational or macroeconomic factors impacting profitability.

EV/EBITDA Ratio

The EV/EBITDA ratio was approximately 13.44 in 2021 and 13.31 in 2022, indicating a relatively stable valuation multiple. A significant increase occurred in 2023, with the ratio rising to 20.79. This trend continued into 2024, reaching 26.97, and remained high at 26.08 in 2025. The increasing ratio, coupled with the fluctuating EBITDA, suggests that the market valuation of the enterprise is growing at a faster rate than its operational earnings. This could be due to factors such as increased investor confidence, expectations of future growth, or changes in the risk profile of the company. The ratio’s increase is primarily driven by the combination of growing Enterprise Value and declining EBITDA between 2022 and 2024.

The divergence between Enterprise Value growth and EBITDA fluctuations warrants further investigation to understand the underlying drivers and potential implications for the company’s financial health and future performance.